• Thu news: Industry M&A volume down 8% over 2023. Pfizer’s Ibrance improves breast cancer survival. Lonza shedding capsule biz. AZ’s Lynparza in early breast cancer. Trump wants childhood vaccine discussion. See more on our front page

What's the deal?

anonymous

Guest
I got a call from a recruiter, but I've heard a lot of people are leaving. What's happening? Is it because of Roche? Is there still money to be made at Foundation Medicine?